Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: A meta-analysis.

Yang, Mingyang; Li, Anthony; Wang, Yushu; Tran, Carolyn; Zhao, Siyi; Ao, Guangyu

Yang, Mingyang; Li, Anthony; Wang, Yushu; Tran, Carolyn; Zhao, Siyi; Ao, Guangyu.

Yang M; West China Fourth Hospital/West China School of Public Health, Sichuan University, Chengdu, Sichuan, China; Health Emergency Management Research Center, China-PUMC C.C. Chen Institute of Health, Sichuan University, Chengdu, Sichuan, China.
Li A; School of Medicine, Queen's University, Kingston, Canada.
Wang Y; Chengdu West China Clinical Research Center, Chengdu, Sichuan, China.
Tran C; Schulich School of Medicine and Dentistry, Western University, London, Canada.
Zhao S; Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Ao G; Department of Nephrology, Chengdu First People's Hospital, Chengdu, Sichuan, China. Electronic address: agy1990418@163.com.

J Infect ; 85(4): 436-480, 2022 10.

Article in English | MEDLINE | ID: covidwho-1914624

Subject(s)

COVID-19; Organ Transplantation; Antibodies, Monoclonal/therapeutic use; Humans; Organ Transplantation/adverse effects; Transplant Recipients

Keywords

COVID-19; Monoclonal antibody; Transplant recipient

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Type of study: Prognostic study / Reviews Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.06.027

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google